Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...

Top officials for the FDA laid out new requirements limiting access to yearly COVID shots for healthy younger adults and ...

US health regulators have given final approval to Novavax's COVID vaccine after an unusual delay and have placed new ...

The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax's COVID-19 vaccine, but only for certain ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.